ETFs

The decision marks a shift for firm, which has largely ridden its equity-fund offerings.

Lower costs are “pushing down what has been the economic model of our industry,” the Schwab EVP says at the In|Vest conference.

Expense ratios associated with the new products range from 0.05% to 0.07%.

The transition is expected to take place within the next 12 to 18 months, however the firm says it will still manage the products’ underlying investments.

Regulators are asking cannabis fund providers to produce third-party legal opinions verifying they don’t violate state or federal laws.

The $3.7 million fund returned more than 40% in the second quarter, outperforming all domestic non-leveraged ETFs.

A new report asks whether the products have the potential to spark another crisis despite being created at the urging of the SEC to reduce risk.

The firm has shed fund holdings in defensive sectors such as health care and consumer staples.

The average expense ratio among the leading 20 is nearly 40 basis points cheaper than what investors paid on average last year.

Outstanding options riding the world’s most heavily traded government debt product are near the highest level this year.